Stephen Hitchcock
SAB
Stephen Hitchcock, Ph.D., is a pharmaceutical R&D executive leader with more than 30 years of experience in biotech and large pharma (Takeda, Eli Lilly, and Amgen). As the former Chief Scientific Officer and Head of Global Research at Takeda, he directed the global research teams responsible for delivering clinical candidates against historically intractable targets across multiple therapeutic areas. He is currently a Venture Partner at 5AM Ventures and the CEO of Implexsys Bioscience.